Patient-reported outcomes (PROs) among patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) receiving pirtobrutinib: Analysis from the BRUIN phase 1/2 study Meeting Abstract


Authors: Coombs, C. C.; Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Tam, C. S.; Seymour, J. F.; Shah, N. N.; Flinn, I. W.; Cheah, C. Y.; Ma, S.; Rhodes, J. M.; Izutsu, K.; Jurczak, W.; Wierda, W. G.; Loubert, A.; Payakachat, N.; Hess, L. M.; Abada, P.; Lamanna, N.
Abstract Title: Patient-reported outcomes (PROs) among patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) receiving pirtobrutinib: Analysis from the BRUIN phase 1/2 study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 6535
Language: English
ACCESSION: WOS:001159900805199
DOI: 10.1182/blood-2023-186145
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lindsey Elizabeth Roeker
    132 Roeker